Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Reserpine (N1867): Practical Lab Workflow Guide

    2026-08-20

    Reserpine (SKU N1867): Practical Lab Workflow Guide

    Reserpine is a bioactive natural-product alkaloid from Rauvolfia plants, identified by CAS No. 50-55-5 and a molecular weight of 608.27. The product dossier describes a solid compound that is insoluble in water and ethanol but soluble in DMSO at concentrations of at least 13 mg/mL with gentle warming. These properties make solvent handling and solution age central to reproducible laboratory work.

    This guide is written for no-paper mode: no directly matched paper evidence is being used, and no study-specific dose, cell model, animal outcome, or clinical result is inferred. The recommendations below are based on the product dossier and standard compound-handling practice. For record matching, retain the name Reserpine together with the search term 3,20-Yohimban-16-carboxylic acid, then confirm identity against the CAS number and analytical documentation.

    What This Product Solves

    In neurotransmitter depletion research and neuropharmacology research, reproducibility can be affected before an assay begins. A compound may be weighed correctly but still produce variable results if it is placed in an unsuitable solvent, incompletely dissolved, exposed to repeated environmental changes, or used after prolonged solution storage. Reserpine N1867 addresses the material-standardization part of this problem by providing a defined solid with reported purity above 98.8%, confirmed by HPLC and NMR analyses.

    The most important operational decision is solvent selection. Because the dossier reports insolubility in water and ethanol, these solvents should not be used as primary dissolution media. DMSO is the documented solvent option, with solubility reported at concentrations of at least 13 mg/mL when gentle warming is used. The stated value is a product-specific solubility condition, not a universal assay concentration or a recommendation to expose every biological system to that DMSO level.

    The material is relevant to controlled studies of neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology. Those research contexts do not establish a clinical conclusion about hypertension, and they should not be treated as evidence for diagnostic or therapeutic use. The Reserpine product information should be checked alongside the laboratory certificate and the approved experimental protocol before use.

    For a parameter-focused companion, see Reserpine (SKU N1867): Workflow Parameters for Lab Use; it complements this article by organizing the same handling considerations around routine laboratory execution. For broader handling guidance, Reserpine (N1867): Technical Guidelines for Lab Research Use provides a related overview of storage, solubility, and research-only boundaries.

    Protocol Parameters

    • Assay: Initial stock-solubility preparation; Value: DMSO at concentrations of at least 13 mg/mL, with gentle warming; Applicability: Preparation of a concentrated laboratory stock before assay-specific dilution; Rationale: The dossier identifies DMSO as the compatible solvent and reports this solubility condition, while water and ethanol are unsuitable primary dissolution media; Evidence basis: Product specification.
    • Assay: Solid-material storage; Value: -20 °C in a sealed, cool, and dry condition; Applicability: Storage of the unopened or appropriately resealed solid material; Rationale: Controlled low-temperature, low-moisture storage is specified to help maintain compound stability; Evidence basis: Product specification.
    • Assay: Solution-use interval; Value: Prepare samples freshly and avoid long-term storage of solutions; Applicability: Stock and working solutions used in biological or biochemical experiments; Rationale: The dossier recommends fresh samples for experimental consistency and does not provide a validated long-term solution stability period; Evidence basis: Product specification plus workflow recommendation.
    • Assay: Identity and purity confirmation; Value: CAS No. 50-55-5, molecular weight 608.27, and purity above 98.8%; Applicability: Reagent qualification, batch records, and preparation calculations; Rationale: These identifiers help distinguish the intended material and support mass-to-molarity calculations; Evidence basis: Product specification.
    • Assay: Quantitative stock preparation; Value: Use the relationship mass = concentration × volume × 608.27 g/mol, with any purity correction based on the current certificate; Applicability: Preparation of molar stocks when the experimental protocol specifies a target concentration; Rationale: Molecular weight converts the planned molar amount to mass, while certificate-specific purity prevents overinterpretation of the nominal amount; Evidence basis: Workflow recommendation using the product molecular weight.

    Workflow Setup and QC Checklist

    Before opening the vial

    • Confirm the product name, SKU N1867, CAS No. 50-55-5, lot information, and current certificate of analysis in the electronic or paper record.
    • Verify that the solid has been transported and received under appropriate cold-chain conditions. The dossier specifies blue ice shipping for this small molecule; promptly document receipt and place the material into the designated -20 °C storage location.
    • Define the required stock and working-solution volumes before weighing. Include the planned vehicle-control volume in the assay map so that treated and control samples receive comparable solvent exposure.

    During dissolution

    • Use a clean, dry vessel and a calibrated balance suitable for the planned mass. Record the actual mass, solvent lot, preparation date, operator, and calculated concentration.
    • Add DMSO in a controlled volume and mix thoroughly. If needed, apply only gentle warming while mixing; do not treat heating as a substitute for verifying complete dissolution.
    • Inspect the solution for visible particles, persistent haze, or precipitate. If the material does not dissolve as expected, stop the assay preparation and investigate solvent volume, mixing, temperature exposure, and material identity rather than proceeding with an unverified stock.

    Before assay addition

    • Prepare the working solution close to the time of use and document the dilution sequence. Because Reserpine is insoluble in water and ethanol, confirm that aqueous dilution does not produce precipitation before adding the preparation to samples.
    • Include a vehicle control, untreated control, and any assay-specific positive or negative controls required by the experimental design. These controls are workflow recommendations, not product-derived biological claims.
    • Record the stock appearance, working-solution appearance, preparation time, and disposition after the run. Do not return an old working solution to the primary solid-material container.

    Common Failure Modes and Fixes

    Precipitation after dilution

    Likely cause: Reserpine was dissolved in an unsuitable solvent or the DMSO stock became locally supersaturated during aqueous dilution. Fix: Recheck the dissolution solvent, mixing order, dilution rate, and final vehicle content. Use a fresh, verified stock and visually inspect the preparation before dosing or sample addition. Do not report a nominal concentration for a preparation that contains visible undissolved material.

    Variable results between runs

    Likely cause: Different solution ages, inconsistent warming, undocumented stock concentrations, or unequal vehicle exposure. Fix: Standardize the preparation record, use freshly prepared solutions, keep the dissolution sequence consistent, and match vehicle volumes across controls and treated samples.

    Incorrect mass-to-concentration conversion

    Likely cause: The molecular weight or certificate-specific purity was omitted from the calculation. Fix: Use 608.27 g/mol for the nominal molecular-weight conversion and apply a documented purity correction when quantitative accuracy requires it. Have a second person check the calculation for critical experiments.

    Loss of material integrity during storage

    Likely cause: Repeated exposure to room air, moisture, or unsuitable temperature conditions. Fix: Keep the solid sealed, cool, and dry at -20 °C, limit unnecessary vial opening, and document any excursion. Avoid creating a large reserve of solution because the dossier specifically recommends against long-term solution storage.

    Identity or documentation mismatch

    Likely cause: A sample is labeled only with an informal name, such as a search synonym, without CAS or lot information. Fix: Reconcile the label, SKU, CAS number, certificate, and experimental record before use. This is particularly important when searching records under 3,20-Yohimban-16-carboxylic acid or other alternate catalog terminology.

    Scope and Limitations

    This article does not provide a universal biological protocol, dosing schedule, exposure time, or expected assay result. The dossier supports use as a research compound in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research, but it does not supply direct evidence for a particular cell type, species, endpoint, or hypertension model. Experimental concentrations and treatment conditions must therefore come from the validated study design, institutional procedures, and assay-specific controls.

    Reserpine N1867 is for research use only. It is not intended for diagnostic, medical, therapeutic, clinical, or veterinary applications. Researchers should perform an independent safety review, consult the applicable safety data sheet, use appropriate personal protective equipment, and manage DMSO-containing waste according to institutional requirements. No conclusion about human or animal treatment should be drawn from the product description alone.

    Conclusion

    Reliable use of Reserpine N1867 depends on disciplined preparation rather than an assumed biological outcome. Confirm the identity and certificate, store the solid at -20 °C in sealed and dry conditions, dissolve in DMSO using gentle warming when needed, verify visual clarity after dilution, and prepare solutions freshly. These steps address the main controllable sources of variation while keeping interpretation within the documented research scope.